Patents Assigned to Janssen Oncology, Inc.
  • Methods and compositions for treating cancer
    Patent number: 10702540
    Abstract: Methods and compositions for treating cancer are described herein. More particularly, the methods for treating cancer comprise administering a 17?-hydroxylase/C17, 20-lyase inhibitor, such as abiraterone acetate (i.e., 3?-acetoxy-17-(3-pyridyl) androsta-5, 16-diene), in combination with at least one additional therapeutic agent such as an anti-cancer agent or a steroid. Furthermore, disclosed are compositions comprising a 17?-hydroxylase/C17, 20-lyase inhibitor, and at least one additional therapeutic agent, such as an anti-cancer agent or a steroid.
    Type: Grant
    Filed: September 13, 2017
    Date of Patent: July 7, 2020
    Assignees: Janssen Oncology, Inc., British Technology Group Limited
    Inventors: Alan H. Auerbach, Arie S. Belldegrun, Johann de Bono
  • Methods and compositions for treating cancer
    Patent number: 8822438
    Abstract: Methods and compositions for treating cancer are described herein. More particularly, the methods for treating cancer comprise administering a 17?-hydroxylase/C17,20-lyase inhibitor, such as abiraterone acetate (i.e., 3?-acetoxy-17-(3-pyridyl)androsta-5,16-diene), in combination with at least one additional therapeutic agent such as an anti-cancer agent or a steroid. Furthermore, disclosed are compositions comprising a 17?-hydroxylase/C17,20-lyase inhibitor, and at least one additional therapeutic agent, such as an anti-cancer agent or a steroid.
    Type: Grant
    Filed: February 24, 2011
    Date of Patent: September 2, 2014
    Assignee: Janssen Oncology, Inc.
    Inventors: Alan H. Auerbach, Arie S. Belldegrum